Screener
Aura Biosciences, Inc. AURA Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income (expense) | 2 | (24) |
| Total other income | 1,192 | 1,570 |
| Loss before income taxes | (33,674) | (27,465) |
| Income tax provision, net | (11) | (18) |
| Net loss | $(33,685) | $(27,483) |
| Net loss per common share—basic and diluted | $(0.50) | $(0.55) |
| Weighted average common stock outstanding—basic and diluted | 67,447,576 | 50,126,148 |
| Comprehensive loss: |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s income tax?
- Aura Biosciences, Inc. (AURA) reported income tax of $11K in Q1 2026.
- How has Aura Biosciences, Inc.'s income tax changed year-over-year?
- Aura Biosciences, Inc.'s income tax decreased by 38.9% year-over-year, from $18K to $11K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Aura Biosciences, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude